Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Trinity Biotech (TRIB) Times Interest Earned (2016 - 2024)

Trinity Biotech's Times Interest Earned history spans 16 years, with the latest figure at $3.41 for Q4 2024.

  • On a quarterly basis, Times Interest Earned rose 110.58% to $3.41 in Q4 2024 year-over-year; TTM through Dec 2024 was $3.27, a 33.98% increase, with the full-year FY2025 number at -$0.74, up 66.64% from a year prior.
  • Times Interest Earned hit $3.41 in Q4 2024 for Trinity Biotech, up from $1.43 in the prior quarter.
  • Over the last five years, Times Interest Earned for TRIB hit a ceiling of $11.52 in Q1 2024 and a floor of -$7.48 in Q3 2020.
  • Historically, Times Interest Earned has averaged $0.59 across 5 years, with a median of $0.22 in 2022.
  • Biggest five-year swings in Times Interest Earned: tumbled 587.72% in 2020 and later skyrocketed 1923.82% in 2022.
  • Tracing TRIB's Times Interest Earned over 5 years: stood at -$7.41 in 2020, then surged by 97.47% to -$0.19 in 2021, then surged by 1923.82% to $3.42 in 2022, then plummeted by 52.74% to $1.62 in 2023, then skyrocketed by 110.58% to $3.41 in 2024.
  • Business Quant data shows Times Interest Earned for TRIB at $3.41 in Q4 2024, $1.43 in Q2 2024, and $11.52 in Q1 2024.